CLINICALLY ISOLATED SYNDROME
Clinical trials for CLINICALLY ISOLATED SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CLINICALLY ISOLATED SYNDROME trials appear
Sign up with your email to follow new studies for CLINICALLY ISOLATED SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study reveals how MS drug passes through breastmilk to babies
Knowledge-focused CompletedThis study looked at how much of the multiple sclerosis (MS) drug ocrelizumab gets into breastmilk and whether it affects babies' immune cells. Twenty-six breastfeeding women with MS or a first MS-like episode took part. Researchers measured drug levels in breastmilk and checked …
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated May 17, 2026 02:45 UTC
-
New tools aim to spot nerve damage early in MS
Knowledge-focused CompletedThis study followed 134 people who had a first episode of neurological symptoms (clinically isolated syndrome) that could lead to multiple sclerosis. Researchers used MRI scans and eye exams to detect and track nerve damage over time. The goal was to develop better ways to predic…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 17, 2026 02:38 UTC
-
MS drug in pregnancy: what happens to Baby's immune cells?
Knowledge-focused CompletedThis study looked at 70 pregnant women with multiple sclerosis or clinically isolated syndrome who took the drug ocrelizumab before or during early pregnancy. Researchers measured B cell levels in their babies to see if the drug crossed the placenta. The goal was to gather safety…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated May 05, 2026 11:54 UTC